What’s the Risk of Relapse After Non-Hodgkin Lymphoma Treatment?

The risk of relapse after treatment for non-hodgkin lymphoma ranges based on factors including biology of the tumor, stage of cancer, and the patient's age.

×
NOW
PLAYING
All About Follicular Lymphoma
NOW
PLAYING
Making a Plan After Non-Hodgkin Lymphoma Relapse
NOW
PLAYING
Non-Hodgkin Lymphoma Treatment - and Beyond
NOW
PLAYING
Treatment After Relapse: Combatting Non-Hodgkin Lymphoma the Second Time Around
NOW
PLAYING
Richter's Transformation: When a Slow-Growing Cancer Turns Aggressive
NOW
PLAYING
CAR T-Cell Therapy for Non-Hodgkin Lymphoma

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.